ARWR
ARROWHEAD PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$61.65
+3.56%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 30.18x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 18.71x
- Price / sales
- 13.01x
- Price / cash flow
- -147.46x
Enterprise value
- Enterprise value
- $8.0B
- EV / sales
- 11.91x
- EV / EBITDA
- -59.63x
- EV / EBIT
- -35.20x
- Market cap
- $8.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026